Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies.

Automation, AI, and human organoids enable researchers to move away from outdated 2D cell cultures and animal models, ...

Stuart H. Orkin, MD, Investigator at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, David G. Nathan Distinguished Professor, Harvard ...

LOS ANGELES, April 19, 2026 /PRNewswire/ -- The Breakthrough Prize Foundation today announced the winners of the 2026 Breakthrough Prizes, honoring scientists whose discoveries are significantly ...

Brandon Dawson, co-founder of 10X Health System and Cardone Ventures, outlines how genetics, biomarkers, and AI are reshaping modern wellness, as the company pushes a data-driven model of personalised ...

The sun, pollution, fast food and smoking are all known culprits, but there are lesser-known factors that could speed up your ...

Discover how Fanny Angelina Hesse revolutionized microbiology by introducing agar, transforming scientific practices and ...

Engineers interested in creating artificial cells to deliver drugs to unhealthy parts of the body face a key challenge: for a ...

In patients developing end-stage liver disease, the damage has become too severe for the liver's normally extraordinary ...